Skip to content
★ Sign in to follow
株式会社Veritas In Silico logo

株式会社Veritas In Silico Stock: price and insider trades · Japan

JP·Mcap JP¥2.7BHealth Care

株式会社Veritas In Silico: what insiders have been doing

Insider filings for 株式会社Veritas In Silico are scarce in the EDINET (Japan FSA) feed, the latest one published on 5 November 2026. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.

Insider Decl.
12
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

JP¥410
Analyst consensus
·
Income statement
RevenueJP¥91.1M
EBITDA-JP¥380.8M-418% margin
Net income-JP¥425.7M-467.1% margin
Valuation
P/Book1.5x
Beta-0.27
Balance sheet & cash
Market capJP¥2.7B
Free Cash Flow-JP¥330.5M
Profitability & ownership
ROE-21.3%
ROA-12.0%
% insiders50.2%
% institutions14.2%
Last declaration on 5 November 2026
Declarations12 total

12 of 12 declarations

About 株式会社Veritas In Silico

Veritas In Silico is a company listed on the XTKS market, specializing in the development of technological solutions for data analysis. It focuses on innovation in the life sciences sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations